Peptide Vaccination against Cytomegalovirus Induces Specific T Cell Response in Responses in CMV Seronegative End-Stage Renal Disease Patients

Introduction: Cytomegalovirus (CMV) reactivation occurs in seronegative patients after solid organ transplantation (SOT) particularly from seropositive donors and can be lethal. Generation of CMV-specific T cells helps to prevent CMV reactivation. Therefore, we initiated a clinical phase I CMVpp65 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommerer, Claudia, Schmitt, Anita, Hückelhoven-Krauss, Angela, Giese, Thomas, Bruckner, Thomas, Wang, Lei, Schnitzler, Paul, Meuer, Stefan, Zeier, Martin, Schmitt, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915922/
https://www.ncbi.nlm.nih.gov/pubmed/33562163
http://dx.doi.org/10.3390/vaccines9020133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915922/
https://www.ncbi.nlm.nih.gov/pubmed/33562163
http://dx.doi.org/10.3390/vaccines9020133

Ejemplares similares